Efficacy of cyclin-dependent kinase 4/6 inhibitors in combination with hormonal therapy in patients with recurrent granulosa cell tumor of the ovary: A case series

Cyclin-dependent kinase inhibitors are approved in combination with hormonal therapy for treatment of hormone receptor expressing breast cancers. Activity in hormone receptor expressing gynecologic cancers has been postulated. Granulosa cell tumor of the ovary is one such cancer, which is relatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Albright, Benjamin B., Shuey, Stephanie, Alvarez Secord, Angeles, Havrilesky, Laura J., Berchuck, Andrew, Previs, Rebecca A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Survey Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682825/
https://www.ncbi.nlm.nih.gov/pubmed/38033361
http://dx.doi.org/10.1016/j.gore.2023.101297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682825/
https://www.ncbi.nlm.nih.gov/pubmed/38033361
http://dx.doi.org/10.1016/j.gore.2023.101297

Ejemplares similares